The FDA today issued a Class I recall for both Terumo Cardiovascular Systems Coronary Ostia Cannula and Maquet Datascopes intra-aortic balloon pumps for defective parts.

The FDA has approved a new genetic test that will help healthcare professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment.

Siemens Healthcare Luminos Agile Fluoroscopy/Radiography system has received 510(k) clearance from the FDA and is now commercially available in the U.S.

Cardinal Health has opened its first cyclotron facility in the state of Georgia, expanding its capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease.

Positron, a nuclear cardiology company, has executed a memorandum of understanding with the City of Noblesville, Ind., to relocate its corporate headquarters, research & development and product manufacturing facilities to Noblesville.

Cetuximab combined with chemoradiotherapy increases lung cancer survival while inducing side effects comparable to chemotherapy alone, offering promising phase II results that clinicians hope will roll over to an ongoing phase III trial.

Konica Minolta Medical Imagings Regius Sigma tabletop CR reader has received 510(k) clearance from the FDA.

For nearly 40 years, residents have had to decide between one of two tracks for nuclear medicine training, a fragmented and outdated system that, thanks to shifts toward healthcare reform and molecular imaging, must be reconciled, according to a joint Society of Nuclear Medicine (SNM) and American College of Radiology (ACR) task force article published in the June issue of The Journal of Nuclear Medicine.